S100A11 Antibody

KD/KO Validated

KD/KO Validated

Expression of S100A11 is often enhanced in diverse types of human cancers. Wang et al., while working with Proteintech antibody, suggested that S100A11 could be a helpful marker, especially for the classification of different stages of colorectal cancer.¹ While performing IHC and WB analysis, researchers also reported that protein levels of S100A11 were overexpressed in adenocarcinomas (ADC) and squamous cell carcinomas (SCC) when compared with noncancerous lung tissues.² 

Immunohistochemical staining of paraffin-embedded human breast cancer tissue slide using S100A11 antibody (10237-1-AP) at a dilution of 1:200 (under 40x lens). Heat-mediated antigen retrieved with TrisEDTA buffer (pH9).

Related Products

Antibody Catalog number Type Applications  
 S100A4 - KD/KO Validated  16105-1-AP  Rabbit Poly  ELISA, WB, IP, IHC, IF  7 Publications
 S100A6 - KD/KO Validated  10245-1-AP  Rabbit Poly  ELISA, FC, IF, IHC, IP, WB  8 Publications
 S100A8 - KD/KO Validated  15792-1-AP  Rabbit Poly  ELISA, IF, IHC, WB  2 Publications
 S100A9  14226-1-AP  Rabbit Poly  ELISA, WB, IHC  
 S100A10  66227-1-Ig  Mouse Mono  ELISA, WB, IHC  
 S100A14 - KD/KO Validated  10489-1-AP  Rabbit Poly  ELISA, IF, IHC, IP, WB  12 Publications
 Annexin A1  66344-1-Ig   Mouse Mono  ELISA, IF, IHC, WB  
 Annexin A2 - KD/KO Validated  11256-1-AP  Rabbit Poly  ELISA, IF, IHC, IP, WB  16 Publications
 RAD51  14961-1-AP  Rabbit Poly  ELISA, IF, IHC, IP, WB  6 Publications
 UPAR  10286-1-AP Rabbit Poly  ELISA, FC, IF, IP, WB  2 Publications

References

1. Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues, (PMID: 18340452).

2. Selective expression of S100A11 in lung cancer and its role in regulating proliferation of adenocarcinomas cells, (PMID: 21861103).

Featured Products

Posted:
20 September, 2017

Share:


Back
to top